Back to results
US 6,673,802 B2Granted
Compounds specific to adenosine A3 receptor and uses thereof
AssigneeOSI Pharmaceuticals, Inc.
InventorsArlindo L. Castelhano, Bryan McKibben, David J. Witter
Life of this patent
Estimating the term…
Abstract
The subject invention provides a compound having the structure: or a pharmaceutically acceptable salt thereof and a method for treating a disease associated with the A3 adenosine receptor by administering a therapeutically effective amount of the compound.
Claims16
A compound having the structure:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.